Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Infection in Hematological Malignancies Patients”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Ended earlyNCT04379518
What this trial is testing

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
Roswell Park Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Not applicableStudy completedNCT05164016
What this trial is testing

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Who this might be right for
CancerHematopoietic System--CancerTransplant-Related Cancer+5 more
St. Jude Children's Research Hospital 21
Testing effectiveness (Phase 2)Ended earlyNCT04370834
What this trial is testing

Tocilizumab for Patients With Cancer and COVID-19 Disease

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmPneumonia+3 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT04932967
What this trial is testing

Use of nMoABs for the Treatment of COVID-19 in Patients With HM.

Who this might be right for
Covid19Hematological Malignancy
Gruppo Italiano Malattie EMatologiche dell'Adulto 91
Not applicableStudy completedNCT06576102
What this trial is testing

Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

Who this might be right for
Persistent COVID-19B Cell Malignancies
Maddalena Giannella 204
Not applicableUnknownNCT04878822
What this trial is testing

Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies

Who this might be right for
ImmunogenicityHematological MalignanciesCovid-19+1 more
Ospedale di Circolo - Fondazione Macchi 300
Not applicableActive Not RecruitingNCT04650178
What this trial is testing

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 274
Not applicableUnknownNCT04581187
What this trial is testing

An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Gruppo Italiano Malattie EMatologiche dell'Adulto 400
Early research (Phase 1)Ended earlyNCT05101213
What this trial is testing

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegaloviral Infection+4 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT04532372
What this trial is testing

Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
City of Hope Medical Center 2
Not applicableLooking for participantsNCT04733729
What this trial is testing

Covid-19 in Hematological Malignancies

Who this might be right for
COVID-19 Infection in Hematological Malignancies Patients
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 3,000
Not applicableStudy completedNCT04760184
What this trial is testing

Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

Who this might be right for
Covid19Myeloma MultipleMalignant Lymphoma+2 more
Uppsala University 20
Testing effectiveness (Phase 2)Study completedNCT04333914
What this trial is testing

Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 (COVID-19) InfectionAdvanced or Metastatic Hematological or Solid Tumor
Centre Leon Berard 19
Early research (Phase 1)Study completedNCT04419623
What this trial is testing

TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

Who this might be right for
COVID-19Sars-CoV2Cancer+3 more
Telios Pharma, Inc. 7
Not applicableUnknownNCT04776005
What this trial is testing

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

Who this might be right for
Solid TumorHematologic MalignancyThoracic Cancer+2 more
Assistance Publique - Hôpitaux de Paris 500
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Very early researchStudy completedNCT04742595
What this trial is testing

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04977024
What this trial is testing

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid System NeoplasmLeukemia+2 more
GeoVax, Inc. 63
Testing effectiveness (Phase 2)WithdrawnNCT04392128
What this trial is testing

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Who this might be right for
COVID19Hematologic Malignancy
Institut de cancérologie Strasbourg Europe
Next Page